243 related articles for article (PubMed ID: 27870591)
1. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
[TBL] [Abstract][Full Text] [Related]
2. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells.
Erwin-Cohen R; Porter A; Pittman P; Rossi C; Dasilva L
Hum Vaccin Immunother; 2012 Aug; 8(8):1053-65. PubMed ID: 22617845
[TBL] [Abstract][Full Text] [Related]
3. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
[TBL] [Abstract][Full Text] [Related]
4. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.
Tretyakova I; Lukashevich IS; Glass P; Wang E; Weaver S; Pushko P
Vaccine; 2013 Feb; 31(7):1019-25. PubMed ID: 23287629
[TBL] [Abstract][Full Text] [Related]
5. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
6. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
Phillpotts RJ
Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
[TBL] [Abstract][Full Text] [Related]
7. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus.
Elvin SJ; Bennett AM; Phillpotts RJ
J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032
[TBL] [Abstract][Full Text] [Related]
8. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
[TBL] [Abstract][Full Text] [Related]
9. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
[TBL] [Abstract][Full Text] [Related]
10. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
Guerbois M; Volkova E; Forrester NL; Rossi SL; Frolov I; Weaver SC
PLoS Negl Trop Dis; 2013; 7(5):e2197. PubMed ID: 23675542
[TBL] [Abstract][Full Text] [Related]
11. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters.
Jahrling PB; Stephenson EH
J Clin Microbiol; 1984 Mar; 19(3):429-31. PubMed ID: 6715512
[TBL] [Abstract][Full Text] [Related]
13. Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.
Turell MJ; Parker MD
Am J Trop Med Hyg; 2008 Feb; 78(2):328-32. PubMed ID: 18256440
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for Venezuelan equine encephalitis.
Paessler S; Weaver SC
Vaccine; 2009 Nov; 27 Suppl 4():D80-5. PubMed ID: 19837294
[TBL] [Abstract][Full Text] [Related]
15. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
[TBL] [Abstract][Full Text] [Related]
16. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
17. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
[TBL] [Abstract][Full Text] [Related]
18. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
[TBL] [Abstract][Full Text] [Related]
19. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
[TBL] [Abstract][Full Text] [Related]
20. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus.
Gupta P; Sharma A; Spurgers KB; Bakken RR; Eccleston LT; Cohen JW; Honnold SP; Glass PJ; Maheshwari RK
Vaccine; 2016 May; 34(25):2762-5. PubMed ID: 27129427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
